GlucoTrack IncEigentümerstruktur
| Preis (2026-07-27) | 52W Hoch | 52W Tief |
| 0.3039 USD | 14,14 USD | 0,288 USD |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| - USD | - | - | - | - | - |
| #Shares | Short [%] | Short Ratio |
| 6.559.279 | 36,48 | 0,4 |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name GlucoTrack Inc
Mitarbeiter 15
Handelsplatz NASDAQ
Ticker Symbol GCTK
IPO Datum 2013-04-25
Adresse 301 Route 17 North, Rutherford, NJ, United States, 07070
Webseite https://glucotrack.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Dr. Paul V. Goode Ph.D. | CEO, President & Director |
| 2 | Mr. Avner Gal MBA, MSc.EE | Co-Founder, Chairman Emeritus, Consultant and Member of Scientific & Clinical Advisory Board |
| 3 | Mr. David Malka BA | Co-Founder |
| 4 | Mr. Vincent Wong | Chief Operations Officer |
| 5 | Dr. Mark Tapsak Ph.D. | Chief Scientific Officer |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | Geode Capital Management, LLC | 0,00% | 0,00 Mio. USD |
| 2 | Ikarian Capital, LLC | 0,00% | 0,00 Mio. USD |
| 3 | HRT FINANCIAL LLC | 0,00% | 0,00 Mio. USD |
| 4 | GRANITE ISLANDS PRIVATE WEALTH, LLC | 0,00% | 0,00 Mio. USD |
| 5 | BOOTHBAY FUND MANAGEMENT, LLC | 0,00% | 0,00 Mio. USD |
| 6 | Vanguard Fiduciary Trust Co | 0,00% | 0,00 Mio. USD |
| 7 | ALERUS FINANCIAL NA | 0,00% | 0,00 Mio. USD |
| 8 | Tower Research Capital LLC | 0,00% | 0,00 Mio. USD |
| 9 | UBS Group AG | 0,00% | 0,00 Mio. USD |
| 10 | Newbridge Financial Services Group, Inc. | 0,00% | 0,00 Mio. USD |
| 11 | SBI Securities Co Ltd | 0,00% | 0,00 Mio. USD |
| 12 | Morgan Stanley - Brokerage Accounts | 0,00% | 0,00 Mio. USD |
| 13 | Advisor Group Holdings, Inc. | 0,00% | 0,00 Mio. USD |
| 14 | Bank of America Corp | 0,00% | 0,00 Mio. USD |